Induced Regulatory T Cells Attenuate Poly I:C-Triggered Acute Lung Injury by Modulating Cytokine Responses

Area of Science:

• Immunology
• Pulmonary Medicine
• Cell Therapy

Background:

• Acute lung injury (ALI) is a critical condition marked by severe lung inflammation and edema, leading to high mortality rates.
• The study investigates the potential of induced regulatory T cells (iTregs) as an early therapeutic intervention for ALI.

Purpose of the Study:

• To evaluate the efficacy of iTreg therapy in mitigating ALI using a polyinosinic-polycytidylic acid (poly I:C)-induced murine model.
• To assess the impact of early iTreg administration on the hyperinflammatory response characteristic of ALI.

Main Methods:

• A murine model of ALI was established using intratracheal administration of poly I:C to induce a hyperinflammatory response.
• Mice received intravenous iTreg injections one hour post-poly I:C challenge to target the early injury phase.

Main Results:

• Poly I:C challenge led to elevated proinflammatory cytokines (IL-6, IL-12, TNF-α, IFN-β, IP-10), decreased anti-inflammatory cytokines (IL-10, TGF-β), and increased immune cell infiltration.
• Significant alveolar damage, including thickened walls and edema, was observed in ALI model mice.
• Early iTreg administration effectively suppressed proinflammatory cytokines, normalized IL-10 levels, reduced immune cell infiltration, and mitigated lung tissue damage.

Conclusions:

• iTreg therapy demonstrates significant potential in modulating the hyperinflammatory response associated with ALI.
• These findings suggest that iTreg administration is a promising therapeutic strategy for managing severe inflammatory lung diseases like ALI.